BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
13 results:

  • 1. Comprehensive germline mutation analysis and clinical profile in a large cohort of Brazilian xeroderma pigmentosum patients.
    Santiago KM; Castro LP; Neto JPD; de Nóbrega AF; Pinto CAL; Ashton-Prolla P; Pinto E Vairo F; de Medeiros PFV; Ribeiro EM; Ribeiro BFR; do Valle FF; Doriqui MJR; Leite CHB; Rocha RM; Moura LMS; Munford V; Galante PAF; Menck CFM; Rogatto SR; Achatz MI
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2392-2401. PubMed ID: 32239545
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.
    Ishibashi M; Toyoshima M; Zhang X; Hasegawa-Minato J; Shigeta S; Usui T; Kemp CJ; Grandori C; Kitatani K; Yaegashi N
    Sci Rep; 2018 Sep; 8(1):13207. PubMed ID: 30181600
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
    Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating xpc and p27Kip1 translation.
    Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
    Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
    Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.
    Muenyi CS; Pinhas AR; Fan TW; Brock GN; Helm CW; States JC
    Toxicol Sci; 2012 May; 127(1):139-49. PubMed ID: 22331493
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
    Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: xpc polymorphisms modify smoking-related risk.
    Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers.
    Navaraj A; Mori T; El-Deiry WS
    Cancer Biol Ther; 2005 Dec; 4(12):1409-14. PubMed ID: 16357511
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ; Van Moorsel CJ; Lakerveld B; Smid K; Noordhuis P; Comijn EC; Weaver D; Willey JC; Voorn D; Van der Vijgh WJ; Pinedo HM
    Int J Oncol; 2006 Jan; 28(1):237-44. PubMed ID: 16328001
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors.
    Takebayashi Y; Nakayama K; Kanzaki A; Miyashita H; Ogura O; Mori S; Mutoh M; Miyazaki K; Fukumoto M; Pommier Y
    Cancer Lett; 2001 Dec; 174(2):115-25. PubMed ID: 11689286
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines.
    Damia G; Guidi G; D'Incalci M
    Eur J Cancer; 1998 Oct; 34(11):1783-8. PubMed ID: 9893669
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.